Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-06-14 @ 7:28 PM
Study NCT ID:
NCT02661035
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2016-01-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allo HSCT Using RIC for Hematological Diseases
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myelogenous Leukemia | View |
| None | Acute Lymphocytic Leukemia | View |
| None | Chronic Myelogenous Leukemia | View |
| None | Plasma Cell Leukemia | View |
| None | Myelodysplastic Syndromes | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Small Lymphocytic Lymphoma | View |
| None | B-Cell Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Lymphoplasmacytic Lymphoma | View |
| None | Mantle-Cell Lymphoma | View |
| None | Prolymphocytic Leukemia | View |
| None | Lymphoblastic Lymphoma | View |
| None | Burkitt's Lymphoma | View |
| None | Non-Hodgkin's Lymphoma | View |
| None | Multiple Myeloma | View |
| None | Myeloproliferative Syndromes | View |
| None | Hematological Diseases | View |